Braslyn Ltd.
Insider CIK 1642355 · INSG 10% owner · MRTX 10% owner · PAND 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 1,413,475 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 3,578,036 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 332,809 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 287,866 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 30,518 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,201,440 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 203,754 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,135,966 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 189 | $195.52 | $37.0K | 3,135,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 1 | $195.90 | $196 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-10 | 2021-03-10 | 410 | — | $0 | 3,135,967 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 200 | $198.00 | $39.6K | 3,135,557 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 20 | $196.12 | $3.9K | 3,135,757 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 1,107 | $195.82 | $216.8K | 3,134,859 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 4,633 | $197.30 | $914.1K | 3,130,226 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 1 | $191.00 | $191 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-09 | 2021-03-10 | 11,971 | — | $0 | 3,135,967 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 2,237 | $199.08 | $445.3K | 3,123,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 3,993 | $197.81 | $789.9K | 3,126,233 | SEC↗ |
| INSG INSEEGO CORP. | S Sale | 2020-12-16 | 2020-12-16 | 293,848 | $14.37 | $4.22M | 7,614,830 | SEC↗ |
| INSG INSEEGO CORP. | S Sale | 2020-12-15 | 2020-12-16 | 190,590 | $14.81 | $2.82M | 7,908,678 | SEC↗ |
| INSG INSEEGO CORP. | S Sale | 2020-12-14 | 2020-12-16 | 1,721,783 | $15.62 | $26.89M | 8,278,217 | SEC↗ |
| INSG INSEEGO CORP. | S Sale | 2020-12-14 | 2020-12-16 | 178,949 | $16.07 | $2.88M | 8,099,268 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-29 | 2020-10-30 | 104,565 | $5.60 | $585.6K | 3,590,421 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 11,656 | $216.06 | $2.52M | 3,045,570 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 27,992 | $215.08 | $6.02M | 3,057,226 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 2,344 | $214.31 | $502.3K | 3,085,218 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 3,108 | $212.66 | $660.9K | 3,087,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 14,408 | $211.50 | $3.05M | 3,090,670 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 10,599 | $210.58 | $2.23M | 3,105,078 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 15,091 | $209.66 | $3.16M | 3,115,677 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,674 | $208.78 | $349.5K | 3,130,768 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,086 | $207.96 | $225.8K | 3,132,442 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,088 | $206.50 | $224.7K | 3,133,528 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 800 | $205.64 | $164.5K | 3,134,616 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 550 | $203.32 | $111.8K | 3,135,416 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 6,775 | $217.14 | $1.47M | 3,038,795 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 5,912 | $218.04 | $1.29M | 3,032,883 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 663 | $218.85 | $145.1K | 3,032,220 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 818 | $220.02 | $180.0K | 3,031,402 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-29 | 2020-10-30 | 104,565 | — | $0 | 3,135,967 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-29 | 2020-10-30 | 1 | $202.25 | $202 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-28 | 2020-10-30 | 295,438 | $5.60 | $1.65M | 3,694,986 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 38,543 | $204.57 | $7.88M | 3,052,464 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 45,896 | $205.49 | $9.43M | 3,006,568 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 41,266 | $206.50 | $8.52M | 2,965,302 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 38,525 | $207.35 | $7.99M | 2,926,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 25,036 | $208.40 | $5.22M | 2,901,741 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 37,428 | $209.47 | $7.84M | 2,864,313 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 23,283 | $210.31 | $4.90M | 2,841,030 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 500 | $211.06 | $105.5K | 2,840,530 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-28 | 2020-10-30 | 295,438 | — | $0 | 3,135,968 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-28 | 2020-10-30 | 2 | $209.16 | $418 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 44,959 | $203.35 | $9.14M | 3,091,007 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 7,064,136 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 120,460 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 23,622 | — | $0 | 23,622 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 1,385,291 | — | $0 | 1,385,291 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 722,222 | $18.00 | $13.00M | 2,107,513 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-06-12 | 2020-06-16 | 600,006 | $5.60 | $3.36M | 3,990,420 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-06-12 | 2020-06-16 | 600,006 | $5.60 | $3.36M | 3,990,420 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-06-12 | 2020-06-16 | 6 | $72.80 | $437 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-06-12 | 2020-06-16 | 600,006 | — | $0 | 3,135,972 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-06-12 | 2020-06-16 | 600,000 | $69.00 | $41.40M | 2,535,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-06-12 | 2020-06-16 | 600,000 | $97.00 | $58.20M | 2,535,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-06-12 | 2020-06-16 | 6 | $100.69 | $604 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-06-12 | 2020-06-16 | 600,006 | — | $0 | 3,135,972 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-03-10 | 2021-03-10 | 410 | $5.60 | $2.3K | 3,578,040 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-03-09 | 2021-03-10 | 11,971 | $5.60 | $67.0K | 3,578,450 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-03-01 | 2019-03-05 | 275,004 | $5.60 | $1.54M | 4,590,426 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-03-01 | 2019-03-05 | 275,004 | — | $0 | 3,135,970 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-03-01 | 2019-03-05 | 275,000 | $69.00 | $18.98M | 2,860,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2019-03-01 | 2019-03-05 | 4 | $72.80 | $291 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-11-16 | 2017-11-20 | 1,413,475 | $13.00 | $18.38M | 1,413,475 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-11-16 | 2017-11-20 | 801,448 | $13.00 | $10.42M | 801,448 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-11-16 | 2017-11-20 | 144,736 | $13.00 | $1.88M | 1,372,510 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-11-16 | 2017-11-20 | 255,264 | $13.00 | $3.32M | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 189,780 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 78,186 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 78,186 | $7.86 | $614.5K | 513,630 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 189,780 | $7.86 | $1.49M | 1,227,774 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-26 | 2017-01-30 | 19,330 | $5.44 | $105.2K | 2,851,863 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-26 | 2017-01-30 | 28,839 | $5.45 | $157.2K | 2,880,702 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-25 | 2017-01-25 | 30,600 | $5.42 | $165.9K | 2,832,533 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-24 | 2017-01-25 | 27,682 | $5.32 | $147.3K | 2,801,933 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-23 | 2017-01-25 | 19,251 | $5.27 | $101.5K | 2,774,251 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-20 | 2017-01-20 | 23,873 | $5.42 | $129.4K | 2,755,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-19 | 2017-01-20 | 21,085 | $5.48 | $115.5K | 2,731,127 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-18 | 2017-01-20 | 16,200 | $5.50 | $89.1K | 2,710,042 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-17 | 2017-01-17 | 17,800 | $5.50 | $97.9K | 2,693,842 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-13 | 2017-01-17 | 52,311 | $5.49 | $287.2K | 2,676,042 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-12 | 2017-01-17 | 49,776 | $5.50 | $273.8K | 2,623,731 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 4,865,430 | $5.60 | $27.25M | 4,865,430 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 581,870 | $5.60 | $3.26M | 2,573,955 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-06-07 | 2016-06-08 | 161,751 | $9.49 | $1.54M | 1,992,085 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-06-06 | 2016-06-08 | 215,151 | $10.31 | $2.22M | 1,830,334 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-05-06 | 2016-05-09 | 4,500 | $17.15 | $77.2K | 1,615,183 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-05-05 | 2016-05-09 | 61,282 | $18.29 | $1.12M | 1,610,683 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-03-29 | 2016-03-31 | 3,400 | $19.09 | $64.9K | 1,549,401 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-03-28 | 2016-03-28 | 300 | $19.48 | $5.8K | 1,546,001 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-03-24 | 2016-03-28 | 20,548 | $19.36 | $397.8K | 1,545,701 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2016-03-18 | 2016-03-22 | 1,166 | $19.34 | $22.6K | 1,525,153 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2016-03-17 | 2016-03-17 | 375,298 | — | $0 | 1,523,987 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2016-01-15 | 2016-01-15 | 626,189 | — | $0 | 1,148,689 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2016-01-04 | 2016-01-05 | 522,500 | — | $0 | 0 | SEC↗ |